These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7037430)

  • 1. Phosphoryl-Leu-Phe: a potent inhibitor of the degradation of enkephalin by enkephalinase.
    Altstein M; Blumberg S; Vogel Z
    Eur J Pharmacol; 1981 Dec; 76(2-3):299-300. PubMed ID: 7037430
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
    Altstein M; Bachar E; Vogel Z; Blumberg S
    Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
    Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
    Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo potentiation of [D-Ala2]Met-enkephalin amide central effects after administration of an enkephalinase inhibitor.
    Algeri S; Altstein M; de Simone GM; Guardabasso V
    Eur J Pharmacol; 1981 Sep; 74(2-3):261-2. PubMed ID: 7035191
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ("enkephalinase") as neuropeptidase.
    Schwartz JC; Malfroy B; De La Baume S
    Life Sci; 1981 Oct; 29(17):1715-40. PubMed ID: 6272046
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes.
    Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W
    Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
    Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
    Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of Leu- and Met-enkephalin from the corpus striatum.
    Henderson G; Hughes J; Kosterlitz HW
    Nature; 1978 Feb; 271(5646):677-9. PubMed ID: 24181
    [No Abstract]   [Full Text] [Related]  

  • 10. Degradation of exogenous enkephalin in the guinea-pig ileum: relative importance of aminopeptidase, enkephalinase and angiotensin converting enzyme activity.
    Geary LE; Wiley KS; Scott WL; Cohen ML
    J Pharmacol Exp Ther; 1982 Apr; 221(1):104-11. PubMed ID: 6278132
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for a gamma-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of Met5-enkephalin elicited by depolarization.
    Harsing LG; Yang HY; Costa E
    J Pharmacol Exp Ther; 1982 Mar; 220(3):616-20. PubMed ID: 7038094
    [No Abstract]   [Full Text] [Related]  

  • 12. Enkephalinase: selective inhibitors and partial characterization.
    Sullivan S; Akil H; Blacker D; Barchas JD
    Peptides; 1980; 1(1):31-5. PubMed ID: 6264406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-phenylalanine and other enkephalinase inhibitors as pharmacological agents: implications for some important therapeutic application.
    Ehrenpreis S
    Acupunct Electrother Res; 1982; 7(2-3):157-72. PubMed ID: 6128872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of enkephalinase inhibitors: substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides.
    Llorens C; Gacel G; Swerts JP; Perdrisot R; Fournie-Zaluski MC; Schwartz JC; Roques BP
    Biochem Biophys Res Commun; 1980 Oct; 96(4):1710-6. PubMed ID: 7004444
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin releaser.
    Takagi H; Shiomi H; Ueda H; Amano H
    Nature; 1979 Nov; 282(5737):410-2. PubMed ID: 228202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of barbiturates on the degradation of enkephalin by brain enzymes.
    Altstein M; Mittman S; Vogel Z
    Life Sci; 1981 Jan; 28(2):185-91. PubMed ID: 7019612
    [No Abstract]   [Full Text] [Related]  

  • 18. Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membranes show similar sensitivity to inhibitors.
    Fulcher IS; Matsas R; Turner AJ; Kenny AJ
    Biochem J; 1982 May; 203(2):519-22. PubMed ID: 7052059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of an enkephalin degrading membrane-bound metalloendopeptidase: analgesic properties and effects on striatal enkephalin levels.
    Murthy LR; Glick SD; Almenoff J; Wilk S; Orlowski M
    Eur J Pharmacol; 1984 Jul; 102(2):305-13. PubMed ID: 6383843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational studies on the enkephalin releasing peptides. Tyr-Arg and Tyr-D-Arg.
    Manavalan P; Momany FA
    Biochem Biophys Res Commun; 1982 Apr; 105(3):847-54. PubMed ID: 7092903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.